NuCana在2025年ESMO大会上展示了Nuc-7738联合PD-1抑制剂的积极数据,使用原代患者来源的类器官和自体肿瘤浸润淋巴细胞

美股速递
Oct 18

NuCana在2025年ESMO大会上展示了Nuc-7738联合PD-1抑制剂的积极数据,使用原代患者来源的类器官和自体肿瘤浸润淋巴细胞。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10